- Report
- October 2024
- 199 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- August 2024
- 100 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- March 2025
- 196 Pages
Global
From €5201EUR$5,450USD£4,358GBP
- Report
- September 2024
- 148 Pages
Global
From €2862EUR$2,999USD£2,398GBP
- Report
- May 2023
- 140 Pages
Global
From €4723EUR$4,949USD£3,957GBP
- Report
- January 2022
- 117 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- October 2024
- 85 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- March 2025
- 86 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- March 2025
- 134 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- July 2024
- 132 Pages
Global
From €907EUR$950USD£760GBP
Superdisintegrants are pharmaceutical intermediates used to facilitate the disintegration of tablets and capsules in the gastrointestinal tract. They are typically composed of polymers, starches, or cellulose derivatives, and are used to increase the rate of dissolution of the active pharmaceutical ingredient. Superdisintegrants are used in a variety of pharmaceutical formulations, including tablets, capsules, and granules.
Superdisintegrants are used to improve the bioavailability of drugs, reduce the time to onset of action, and improve patient compliance. They are also used to reduce the size of tablets, improve the flowability of powders, and reduce the cost of production.
Some of the companies in the Superdisintegrant market include BASF, Colorcon, Dow, Evonik, JRS Pharma, Roquette, and Wacker Chemie. Show Less Read more